Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cancer Survival Analysis01:21

Cancer Survival Analysis

626
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
626
Tumor Progression02:07

Tumor Progression

7.2K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.2K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

4.6K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.6K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

5.8K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.8K
Cancer Prevention02:59

Cancer Prevention

7.6K
Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
7.6K
Nursing Ethical Principles II01:27

Nursing Ethical Principles II

2.0K
Ethical principles are essential in guiding nurses to fulfill their responsibilities, focusing on the quality of nursing care and decision-making. These principles, including autonomy, beneficence, non-maleficence, justice, and fidelity, shape the ethical framework within healthcare settings.
Consider the following scenario, which illustrates how these principles are applied in the care of Mr. John, a fifty-year-old teacher diagnosed with metastatic liver cancer.
Initially, Mr. John's...
2.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Economic evaluation of adjuvant chemotherapy for non-metastatic sarcoma using the real-world data from the French nationwide DEEPSARC study.

Journal of medical economics·2026
Same author

Hyperprogression after Immune Checkpoint Inhibitors: A Cloudy Phenomenon with Real-life Consequences.

Cancer communications (London, England)·2026
Same author

Challenges and needs among pediatric oncology providers in caring for pediatric brain tumor patients and survivors: A qualitative study.

International journal of clinical and health psychology : IJCHP·2026
Same author

Overall survival of patients with localized soft tissue sarcoma treated with or without adjuvant chemotherapy (DEEPSARC): a real world nationwide retrospective cohort study in France.

EClinicalMedicine·2026
Same author

Neuropsychological outcomes in pediatric brain tumor survivors: contributions of sociocontextual factors.

Child neuropsychology : a journal on normal and abnormal development in childhood and adolescence·2026
Same author

Characteristics and outcome of intra-abdominal desmoid-type fibromatosis.

European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·2026
Same journal

Virga and the future of motivational interviewing: Issues in training counseling skills.

Patient education and counseling·2026
Same journal

Informed choices: Patients' and healthcare professionals' perspectives on high-risk prostate cancer treatment decision-making.

Patient education and counseling·2026
Same journal

Factors influencing patients switching back to physical channels for health consultations.

Patient education and counseling·2026
Same journal

Challenges in advising people with severe mental illness to quit smoking: A conversation analysis of patient resistance.

Patient education and counseling·2026
Same journal

Alleviating the burden: The impact of interpersonal and digital communication on depressive symptoms in cancer survivors.

Patient education and counseling·2026
Same journal

Are patient goals discussed during treatment decision-making in patients with head and neck cancer? A qualitative content analysis of consultations.

Patient education and counseling·2026
See all related articles

Related Experiment Video

Updated: Jan 7, 2026

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
06:46

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Published on: September 27, 2024

619

Cancer progression and shared decision-making: Crossed.

Julia Kolly1, Sophie Lelorain1, Nicolas Penel2

  • 1University of Lausanne, Psychology Institute, Lausanne, Switzerland.

Patient Education and Counseling
|January 1, 2026
PubMed
Summary
This summary is machine-generated.

Cancer treatment decisions during progression consultations often exclude patients and family caregivers (P&Cs). Enhancing communication and integrating P&Cs is crucial for balanced, patient-centered shared decision-making (SDM).

Keywords:
Cancer progressionMedical communicationPsycho-oncologyQualitative methodsShared decision-making

More Related Videos

A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma
12:24

A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma

Published on: September 30, 2021

5.9K
Studying Pancreatic Cancer Stem Cell Characteristics for Developing New Treatment Strategies
07:29

Studying Pancreatic Cancer Stem Cell Characteristics for Developing New Treatment Strategies

Published on: June 20, 2015

20.1K

Related Experiment Videos

Last Updated: Jan 7, 2026

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
06:46

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Published on: September 27, 2024

619
A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma
12:24

A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma

Published on: September 30, 2021

5.9K
Studying Pancreatic Cancer Stem Cell Characteristics for Developing New Treatment Strategies
07:29

Studying Pancreatic Cancer Stem Cell Characteristics for Developing New Treatment Strategies

Published on: June 20, 2015

20.1K

Area of Science:

  • Oncology
  • Healthcare Communication
  • Shared Decision-Making

Background:

  • Cancer progression necessitates treatment changes, involving consultations with patients and family caregivers (P&Cs).
  • Limited research exists on decision-making dynamics within these critical consultations.

Purpose of the Study:

  • To explore how decision-making in cancer progression consultations aligns with shared decision-making (SDM).
  • To understand the perspectives of healthcare professionals (HCPs) and P&Cs on this process.

Main Methods:

  • A qualitative study utilizing 35 semi-structured interviews.
  • Participants included HCPs (n=20), patients (n=10), and family caregivers (n=5).

Main Results:

  • Five themes emerged, including the decision-making process, key consultations, professional-patient-caregiver relationships, perceived choice, and essential decision-making elements.
  • An imbalance in decision-making was observed, with physicians often making decisions before consultations.

Conclusions:

  • Cancer progression consultations have potential for SDM but require adjustments to increase P&C involvement.
  • Strengthening communication, integrating P&Cs, and optimizing interdisciplinary collaboration can foster patient-centered care and improve decision-making.